US 12,064,444 B2
Application of tannic acid in preparation of medicament against respiratory viruses
Jun Fu, Guangdong (CN)
Assigned to SUNTRAP LIFE TECHNOLOGIES LTD., Guangdong (CN)
Appl. No. 17/630,512
Filed by SUNTRAP LIFE TECHNOLOGIES LTD., Guangdong (CN)
PCT Filed Sep. 10, 2020, PCT No. PCT/CN2020/114432
§ 371(c)(1), (2) Date Jan. 27, 2022,
PCT Pub. No. WO2022/036774, PCT Pub. Date Feb. 24, 2022.
Claims priority of application No. 202010826586.2 (CN), filed on Aug. 17, 2020.
Prior Publication US 2022/0354877 A1, Nov. 10, 2022
Int. Cl. A61K 31/14 (2006.01); A61K 9/00 (2006.01); A61K 9/12 (2006.01); A61K 31/05 (2006.01); A61K 31/353 (2006.01); A61K 31/7034 (2006.01); A61K 33/06 (2006.01); A61K 33/24 (2019.01); A61K 33/26 (2006.01); A61K 33/30 (2006.01); A61P 31/14 (2006.01)
CPC A61K 31/7034 (2013.01) [A61K 9/0053 (2013.01); A61K 9/12 (2013.01); A61K 31/05 (2013.01); A61K 31/353 (2013.01); A61K 33/06 (2013.01); A61K 33/24 (2013.01); A61K 33/26 (2013.01); A61K 33/30 (2013.01); A61P 31/14 (2018.01)] 8 Claims
 
1. A method of using a medicament against a novel coronavirus SARS-COV-2, wherein the method comprises:
preparing a medicament comprising tannic acid and zinc gluconate, wherein a mass ratio of the tannic acid to the zinc gluconate is 1:1; and
administering the medicament to a patient infected with the novel coronavirus SARS-CoV-2.